China Central Lab Market Size & Outlook, 2023-2030
China central lab market, 2018-2030 (US$M)
Related Markets
China central lab market highlights
- The China central lab market generated a revenue of USD 160.4 million in 2023 and is expected to reach USD 278.1 million by 2030.
- The China market is expected to grow at a CAGR of 8.2% from 2024 to 2030.
- In terms of segment, biomarker services was the largest revenue generating services in 2023.
- Genetic Services is the most lucrative services segment registering the fastest growth during the forecast period.
Central lab market data book summary
| Market revenue in 2023 | USD 160.4 million |
| Market revenue in 2030 | USD 278.1 million |
| Growth rate | 8.2% (CAGR from 2023 to 2030) |
| Largest segment | Biomarker services |
| Fastest growing segment | Genetic Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services |
| Key market players worldwide | LabConnect, Eurofins Scientific SE, A. P. Moller Maersk A/S ADR, ACM Global, Cerba Research, Synevo Central Labs, Versiti, Cenetron, Ampersand Capital Partners, Pacific Biomarkers, Cirion |
Other key industry trends
- In terms of revenue, China accounted for 4.9% of the global central lab market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan central lab market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 170.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Central Lab Market Scope
Central Lab Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China central lab market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central lab market will help companies and investors design strategic landscapes.
Biomarker services was the largest segment with a revenue share of 38.65% in 2023. Horizon Databook has segmented the China central lab market based on genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services covering the revenue growth of each sub-segment from 2018 to 2030.
China is expected to grow at a lucrative CAGR over the forecast period owing to increasing healthcare expenditure, a growing population, and a high prevalence of chronic diseases.
China represents an attractive option for clinical trials due to the presence of a large, easily accessible, and treatment naïve population, along with the availability of local expertise for trial support. As a result, various contract research organizations and central labs are expanding their presence in China.
For instance, in May 2021, PPD launched a new clinical research laboratory in Suzhou to support the research studies of biotechnology companies in the region. Furthermore, the demand for central labs in China is propelled by the country’s stringent regulations under the Chinese National Medical Products Administration (NMPA).
Reasons to subscribe to China central lab market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China central lab market databook
-
Our clientele includes a mix of central lab market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China central lab market , including forecasts for subscribers. This country databook contains high-level insights into China central lab market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China central lab market size, by services, 2018-2030 (US$M)
China Central Lab Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
